MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Salesforce
CRM
US Stock MarketDetailed Quotes
AVXL Anavex Life Sciences
- 8.225
- -0.075-0.90%
Trading Dec 13 11:49 ET
697.44MMarket Cap-16.13P/E (TTM)
8.800High8.200Low556.13KVolume8.600Open8.300Pre Close4.68MTurnover0.68%Turnover RatioLossP/E (Static)84.80MShares10.45052wk High5.37P/B676.14MFloat Cap3.25052wk Low--Dividend TTM82.21MShs Float31.500Historical High--Div YieldTTM7.23%Amplitude0.600Historical Low8.424Avg Price1Lot Size
Anavex Life Sciences News
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital
Anavex Life Sciences Price Target Maintained With a $46.00/Share by D. Boral Capital
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40
Anavex Life Sciences Analyst Ratings
Anavex Life Sciences: Buy Rating Driven by Promising Blarcamesine Developments and Market Expansion
JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15
Anavex Life Sciences Is Maintained at Buy by EF Hutton
Anavex Life Sciences Analyst Ratings
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40
Buy Rating Affirmed for Anavex Life Sciences Amid Promising Clinical Developments and Market Prospects
Buy Rating on Anavex Life Sciences Amid Anticipated European Approval and Market Opportunity for Alzheimer's Drug Blarcamesine
JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15
Buy Rating on Anavex Life Sciences: Upcoming Catalysts and Positive Trial Outcomes Fuel Optimism
Anavex Life Sciences Analyst Ratings
Buy Rating Affirmed for Anavex Life Sciences on Blarcamesine's Promising Alzheimer's Treatment Potential
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40
JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15
Buy Rating Affirmed: Anavex Life Sciences' Promising Alzheimer's Drug Shows Potential for Approval
Anavex Life Sciences Analyst Ratings
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.